Author

Esin Oktay

Observed names: E Oktay, ESIN OKTAY, Esin OKTAY

Observed institutions: Izmir Kâtip Çelebi University, Adana Hospital, Serik Devlet Hastanesi, Seyhan Devlet Hastanesi, Adıyaman Eğitim ve Araştırma Hastanesi, Pamukkale University, Adnan Menderes University

ORCID: 0000-0002-5974-6339

Observed ORCID: 0000-0002-5974-6339

OpenAlex ID: A5071738025

Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.

1990 · R T Chlebowski, L Bulcavage, et al. · Journal of Clinical Oncology · 77

Role of increased mean platelet volume ( MPV ) and decreased MPV /platelet count ratio as poor prognostic factors in lung cancer

2016 · Muhyettin Omar, Ozgur Tanriverdi, et al. · The Clinical Respiratory Journal · 53

Blastocystis subtypes in cancer patients: Analysis of possible risk factors and clinical characteristics

2016 · Ozlem Yersal, Erdogan Malatyali, et al. · Parasitology International · 52

The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG)

2014 · Ozgur Tanriverdi, Esra Kaytan-Saglam, et al. · Medical Oncology · 44

HALP Score as a New Prognostic Index in Metastatic Renal Cell Cancer

2022 · Ferhat Ekinci, Onur Yazdan Balcik, et al. · Journal of College of Physicians And Surgeons Pakistan · 38

PDF

Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group

2015 · Ozgur Tanriverdi, Nilufer Avci, et al. · Asian Pacific Journal of Cancer Prevention · 36

PDF

Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group

2014 · Ozgur Tanriverdi, Suna Cokmert, et al. · Medical Oncology · 31

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

2023 · Seda Kahraman, Enes Erul, et al. · Future Oncology · 27

The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG).

2016 · Ozgur Tanriverdi, Serkan Menekse, et al. · PubMed · 27

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24

PDF

Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme

2021 · Hatice Yılmaz, Büşra Niğdelioğlu, et al. · Journal of Clinical Neuroscience · 16

Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors.

2019 · Esin Oktay, Gizem Donmez Yalcin, et al. · PubMed · 14

The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma

2018 · Esin Oktay, Utku Oflazoglu, et al. · Journal of Cancer Research and Therapeutics · 14

The Prognostic Importance of Glucose-to-Lymphocyte Ratio and Uric Acid in Metastatic Breast Cancer Patients Treated with Cdk 4/6 Inhibitors

2022 · Hatice Yilmaz, Büsra Nigdelioglu, et al. · Future Oncology · 11

Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study

2024 · Olcun Umit Unal, Seval Akay, et al. · Frontiers in Oncology · 7

Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

2018 · Esin Oktay, Mustafa Levent, et al. · Journal of Cancer Education · 7

Depression and anxiety in oncology nurses.

2018 · Özge Keskin, Esin Oktay, et al. · Journal of Clinical Oncology · 7

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

2017 · Cemil Bilir, İbrahim Yıldız, et al. · Cancer Investigation · 7

KRAS mutation subtypes in metastatic non-small cell lung cancer

2025 · Ali Aytac, Bilgin Demir, et al. · American Journal of Cancer Research · 6

PDF

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 5

PDF

Glutamate Transporter 1 expression in human glioblastomas.

2020 · Gizem Donmez Yalcin, Esin Oktay, et al. · Journal of B.U.ON. : official journal of the Balkan Union of Oncology · 5

Serum procalcitonin levels in patients with ankylosing spondylitis

2014 · Mustafa Ozmen, Esin Oktay, et al. · International Journal of Rheumatic Diseases · 5

The expression of glutamate metabolism modulators in the intracranial tumors and glioblastoma cell line

2021 · Aysenur Akkulak, Düriye Nur Dağdelen, et al. · Molecular Biology Reports · 4

A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).

2019 · Serkan Degirmencioglu, Ozgur Tanriverdi, et al. · PubMed · 4

First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer

2014 · Umut Varol, Ahmet Dirican, et al. · Asian Pacific Journal of Cancer Prevention · 4

PDF

Works count: 59

Citation count: 545

H-index: 13

I10-index: 14